High Ki-67 as a biomarker for identifying patients with high risk early breast cancer treated in monarchE
Harbeck N, Johnston S, Fasching P, Martin M, Toi M, Rastogi P, Song C, Molthrop D, Vuky J, Yamashita T, Jaliffe GG, Gumus M, Headley D, Wei R, Barriga S, Munoz M, Method M, Andre V, Kreipe H, O'Shaughnessy J (2021)
Publication Type: Conference contribution
Publication year: 2021
Journal
Publisher: AMER ASSOC CANCER RESEARCH
City/Town: PHILADELPHIA
Conference Proceedings Title: CANCER RESEARCH
DOI: 10.1158/1538-7445.sabcs20-pd2-01
Authors with CRIS profile
Involved external institutions
Fujian Medical University
China (CN)
Eli Lilly and Company
United States (USA) (US)
Grupo México Camino S.C.
Mexico (MX)
Kyoto University Hospital / 京都大学医学部附属病院
Japan (JP)
University of Pittsburgh
United States (USA) (US)
Hospital General Universitario Gregorio Marañón
Spain (ES)
Texas Oncology
United States (USA) (US)
Medizinische Hochschule Hannover (MHH) / Hannover Medical School
Germany (DE)
Istanbul Medeniyet University / İstanbul Medeniyet Üniversitesi
Turkey (TR)
Royal Marsden Hospital / The Royal Marsden NHS Foundation Trust
United Kingdom (GB)
Oregon Health and Science University (OSHU)
United States (USA) (US)
Kanagawa Prefectural Hospital / Kanagawa Cancer Center / 神奈川県立がんセンター
Japan (JP)
Ludwig-Maximilians-Universität (LMU)
Germany (DE)
China (CN)
Eli Lilly and Company
United States (USA) (US)
Grupo México Camino S.C.
Mexico (MX)
Kyoto University Hospital / 京都大学医学部附属病院
Japan (JP)
University of Pittsburgh
United States (USA) (US)
Hospital General Universitario Gregorio Marañón
Spain (ES)
Texas Oncology
United States (USA) (US)
Medizinische Hochschule Hannover (MHH) / Hannover Medical School
Germany (DE)
Istanbul Medeniyet University / İstanbul Medeniyet Üniversitesi
Turkey (TR)
Royal Marsden Hospital / The Royal Marsden NHS Foundation Trust
United Kingdom (GB)
Oregon Health and Science University (OSHU)
United States (USA) (US)
Kanagawa Prefectural Hospital / Kanagawa Cancer Center / 神奈川県立がんセンター
Japan (JP)
Ludwig-Maximilians-Universität (LMU)
Germany (DE)
How to cite
APA:
Harbeck, N., Johnston, S., Fasching, P., Martin, M., Toi, M., Rastogi, P.,... O'Shaughnessy, J. (2021). High Ki-67 as a biomarker for identifying patients with high risk early breast cancer treated in monarchE. In CANCER RESEARCH. PHILADELPHIA: AMER ASSOC CANCER RESEARCH.
MLA:
Harbeck, Nadia, et al. "High Ki-67 as a biomarker for identifying patients with high risk early breast cancer treated in monarchE." Proceedings of the CANCER RESEARCH PHILADELPHIA: AMER ASSOC CANCER RESEARCH, 2021.
BibTeX: Download